1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
- 2021
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
-
Mark
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
(
- Contribution to journal › Article
- 2020
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
- 2019
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
(
- Contribution to journal › Article
- 2018
-
Mark
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
(
- Contribution to journal › Article
- 2016
-
Mark
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
(
- Contribution to journal › Article